Yishenyangsui granule for degenerative cervical myelopathy: a randomized, double-blind, placebo-controlled trial with long-term follow-up
ObjectiveThis randomized controlled trial aims to evaluate the efficacy and safety of Yishenyangsui granule for treating Degenerative Cervical Myelopathy.Materials and methodsA randomized, double-blind, placebo-controlled clinical trial was conducted with 152 participants recruited from three center...
Saved in:
Main Authors: | He Yin, Xin Chen, Zhiwei Liu, Bo Xu, Zhefeng Jin, Yan Liu, Baoyu Qi, Bin Tang, Ping Wang, Fanping Xu, Xu Wei, Jie Yu, Liguo Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1542231/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
1-year data on patient-reported outcome is enough after surgery for degenerative cervical myelopathy: a cohort study from the Swedish Spine register
by: Lovisa Gerdhem, et al.
Published: (2025-01-01) -
Intramedullary Stress and Strain Correlate with Neurological Dysfunction in Degenerative Cervical Myelopathy
by: Mahmudur Rahman, et al.
Published: (2025-01-01) -
Construction of a nomogram for predicting the prognosis of patients with cervical spondylotic myelopathy: a retrospective study
by: He Ling, et al.
Published: (2024-12-01) -
Differences in Transdiaphragmatic Pressure of Dogs Suffering from Cervical or Thoracolumbar Myelopathy Anaesthetised with Isoflurane
by: Eirini Sarpekidou, et al.
Published: (2025-01-01) -
Diagnostic Dilemmas in Carpal Tunnel Syndrome and Cervical Spine Disorders: A Comprehensive Review
by: Yuki Hara, et al.
Published: (2025-01-01)